Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07549126 · ClinicalTrials.gov registry record · NA
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 267
- Enrollment target
NCT07549126: Completed NA study, sponsored by Yale University.
NCT07549126 is a NA study that has completed, run by Yale University. The registered enrollment target is 267 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07549126, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 267 participants
- Enrollment target
Study Summary
This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
Primary Outcome
Proportion of eligible encounters with a COWS competed, by any team member and via any workflow (internal and external of EMBED). Obtained from EHR data.
Interventions
- OTHER Nurse prompt to complete COWS under required documentation
- OTHER Refined EMBED CDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2026-04-02 |
| Est. Completion | 2026-05-07 |
| Phase | NA |
What the finished NCT07549126 record still lists
NCT07549126 is an interventional study that assigns participants to a tested intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Nurse prompt to complete COWS under required documentation is the first listed.
NCT07549126 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07549126 about?
NCT07549126 is a clinical study titled "Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1". This study is stage 2, round 1 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
What is the current status of trial NCT07549126?
This trial is currently completed. It is a NA study. The enrollment target is 267 participants. The study started on 2026-04-02. Estimated completion is 2026-05-07.
What interventions are being tested in trial NCT07549126?
The interventions under investigation include: Nurse prompt to complete COWS under required documentation (OTHER), Refined EMBED CDS (OTHER).
Who is sponsoring clinical trial NCT07549126?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07549126's enrollment target sits among peer trials
267 395th of 2000 higher than 1,606 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI